Inhibiting 1 protein restores treatment benefit in resistant breast cancer
(Georgetown University Medical Center) A team of researchers has found, in animal models of human breast cancer, that inhibiting a single protein restores sensitivity to tamoxifen, a commonly used drug for treatment of some breast cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2016 Category: Cancer & Oncology Source Type: news
Tamoxifen OK for Breast Cancer Patients Without Uterine Abnormalities: Study
Title: Tamoxifen OK for Breast Cancer Patients Without Uterine Abnormalities: StudyCategory: Health NewsCreated: 9/22/2016 12:00:00 AMLast Editorial Review: 9/23/2016 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 23, 2016 Category: Cancer & Oncology Source Type: news
Tamoxifen OK for Breast Cancer Patients Without Uterine Abnormalities: Study
Pretreatment ultrasounds may reassure women about their uterine cancer risk, researchers say (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - September 23, 2016 Category: Cancer & Oncology Source Type: news
Tamoxifen OK for Breast Cancer Patients Without Uterine Abnormalities: Study
Pretreatment ultrasounds may reassure women about their uterine cancer risk, researchers say (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 22, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Pharmacy, News, Source Type: news
Tamoxifen OK for breast cancer patients without uterine abnormalities: Study
HealthDay News For most women, taking the breast cancer drug tamoxifen doesn't increase their risk of uterine cancer, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 22, 2016 Category: Consumer Health News Source Type: news
Tamoxifen OK for Breast Cancer Patients without Uterine Abnormalities
Pretreatment ultrasounds may reassure women about their uterine cancer risk, researchers saySource: HealthDay
Related MedlinePlus Pages: Breast Cancer, Uterine Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 22, 2016 Category: Consumer Health News Source Type: news
Tamoxifen OK for Breast Cancer Patients Without Uterine Abnormalities: Study
THURSDAY, Sept. 22, 2016 -- For most women, taking the breast cancer drug tamoxifen doesn ' t increase their risk of uterine cancer, a new study suggests.
For women who don ' t already have precancerous abnormalities in the uterine lining... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 22, 2016 Category: Journals (General) Source Type: news
Tamoxifen resistance linked to high estrogen levels in utero
(Georgetown University Medical Center) An animal study suggests that resistance to tamoxifen therapy in some estrogen receptor positive breast cancers may originate from in utero exposure to endocrine disrupting chemicals. The study provides a new path forward in human research as about half of the breast cancers treated with this common cancer therapy do not respond well, say researchers at the Georgetown Lombardi Comprehensive Cancer Center, who led the multi-institutional research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 8, 2016 Category: Cancer & Oncology Source Type: news
Scientists identify genes that disrupt response to breast cancer treatment
(University of Illinois at Urbana-Champaign) In breakthrough research on breast cancer, a team at the University of Illinois discovered that higher levels of the nuclear transport gene XPO1 indicate when a patient is likely to be resistant to the popular drug tamoxifen. The team is led by food science and human nutrition professor Zeynep Madak-Erdogan. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 7, 2016 Category: Cancer & Oncology Source Type: news
Expectations May Influence Side Effects of BC Hormone Therapy Expectations May Influence Side Effects of BC Hormone Therapy
Side effects from taking tamoxifen for breast cancer may be worse if a patient expects they will be bad before therapy even begins, according to a study from Germany.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 2, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Medical News Today: Cancer treatment side effects influenced by patient expectations
Study of breast cancer patients whose treatment included tamoxifen finds their expectations influenced number and severity of experienced side effects. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 24, 2016 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Expecting the worst increases side-effects in breast cancer patients on hormone therapies
A study of women receiving hormone therapies such as tamoxifen as part of their treatment for breast cancer has found that the number and seriousness of side effects they experienced were influenced by their expectations. The study found that women who had higher expectations of suffering more and worse side-effects before their treatment began did, in fact, experience more after two years of adjuvant hormone therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 23, 2016 Category: Science Source Type: news
Expecting the worst increases side-effects in breast cancer patients on hormone therapies
(European Society for Medical Oncology) A study of women receiving hormone therapies such as tamoxifen as part of their treatment for breast cancer has found that the number and seriousness of side effects they experienced were influenced by their expectations. The study, published in Annals of Oncology, found that women who had higher expectations of suffering more and worse side-effects before their treatment began did, in fact, experience more after two years of adjuvant hormone therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 22, 2016 Category: Cancer & Oncology Source Type: news
